These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7555546)

  • 1. Measurement of D-chiro-inositol in clinical studies.
    Ostlund RE; Sherman WR
    Diabetes Care; 1995 Jul; 18(7):1074-5. PubMed ID: 7555546
    [No Abstract]   [Full Text] [Related]  

  • 2. D-chiro-inositol metabolism in diabetes mellitus.
    Ostlund RE; McGill JB; Herskowitz I; Kipnis DM; Santiago JV; Sherman WR
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9988-92. PubMed ID: 8234346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary myo-inositol-to-chiro-inositol ratios and insulin resistance.
    Larner J; Craig JW
    Diabetes Care; 1996 Jan; 19(1):76-8. PubMed ID: 8720541
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus.
    Murphy A; Shamshirsaz A; Markovic D; Ostlund R; Koos B
    Reprod Sci; 2016 Mar; 23(3):365-71. PubMed ID: 26355118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes.
    Suzuki S; Kawasaki H; Satoh Y; Ohtomo M; Hirai M; Hirai A; Hirai S; Onoda M; Matsumoto M; Hinokio Y
    Diabetes Care; 1994 Dec; 17(12):1465-8. PubMed ID: 7882818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus.
    Kennington AS; Hill CR; Craig J; Bogardus C; Raz I; Ortmeyer HK; Hansen BC; Romero G; Larner J
    N Engl J Med; 1990 Aug; 323(6):373-8. PubMed ID: 2370888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary chiro- and myo-inositol levels as a biological marker for type 2 diabetes mellitus.
    Hong JH; Jang HW; Kang YE; Lee JH; Kim KS; Kim HJ; Park KR; Ku BJ
    Dis Markers; 2012; 33(4):193-9. PubMed ID: 22960342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of urinary Myo-/chiro-inositol ratios from Korean diabetes patients.
    Jung TS; Hahm JR; Kim JJ; Jung JH; Kang MY; Moon SW; Lee KW; Kim HC; Lee JD; Kim JH; Kim DR; Chung SI
    Yonsei Med J; 2005 Aug; 46(4):532-8. PubMed ID: 16127779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people.
    Campbell WW; Ostlund RE; Joseph LJ; Farrell PA; Evans WJ
    Horm Metab Res; 2001 Jan; 33(1):44-51. PubMed ID: 11280715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS/MS method for the quantification of myo- and chiro-inositol as the urinary biomarkers of insulin resistance in human urine.
    Kim BH; Park JY; Jang JB; Moon DC
    Biomed Chromatogr; 2012 Apr; 26(4):429-33. PubMed ID: 21830227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between urinary inositol excretions and whole-body glucose tolerance and skeletal muscle insulin receptor phosphorylation.
    Stull AJ; Thyfault JP; Haub MD; Ostlund RE; Campbell WW
    Metabolism; 2008 Nov; 57(11):1545-51. PubMed ID: 18940392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renal excretion of inositol in normal and diabetic human beings.
    DAUGHADAY WH; LARNER J
    J Clin Invest; 1954 Mar; 33(3):326-32. PubMed ID: 13143077
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation, structure, synthesis, and bioactivity of a novel putative insulin mediator. A galactosamine chiro-inositol pseudo-disaccharide Mn2+ chelate with insulin-like activity.
    Larner J; Price JD; Heimark D; Smith L; Rule G; Piccariello T; Fonteles MC; Pontes C; Vale D; Huang L
    J Med Chem; 2003 Jul; 46(15):3283-91. PubMed ID: 12852758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the urinary excretion of meso-inositol in various diseases].
    PERLES R; COLAS MC
    Bull Soc Chim Biol (Paris); 1958; 40(5-6):913-21. PubMed ID: 13596797
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of pinitol treatment on insulin action in subjects with insulin resistance.
    Davis A; Christiansen M; Horowitz JF; Klein S; Hellerstein MK; Ostlund RE
    Diabetes Care; 2000 Jul; 23(7):1000-5. PubMed ID: 10895854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of chiro-inositol and its formation by isomerization of myo-inositol during hydrolysis of glycosylphosphatidylinositol-anchored proteins.
    Taguchi R; Yamazaki J; Tsutsui Y; Ikezawa H
    Arch Biochem Biophys; 1997 Jun; 342(1):161-8. PubMed ID: 9185625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin and the renal handling of glucose.
    Spathis GS
    Clin Sci; 1970 Apr; 38(4):26P-27P. PubMed ID: 5428802
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review.
    Gateva A; Unfer V; Kamenov Z
    Gynecol Endocrinol; 2018 Jul; 34(7):545-550. PubMed ID: 29309199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monosaccharides and polyols in diabetes mellitus and uremia.
    Aloia JF
    J Lab Clin Med; 1973 Nov; 82(5):809-17. PubMed ID: 4746819
    [No Abstract]   [Full Text] [Related]  

  • 20. Urine glucose measurement in the management of diabetes mellitus.
    Reynolds C
    Compr Ther; 1978 Jun; 4(6):13-9. PubMed ID: 97043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.